多中药复方治疗卒中后神经损伤协同效应机制的网络药理学研究
本研究基于TCMSP数据库获取涤痰汤、血府逐瘀汤、小续命汤的草药与化合物,用SEA、HitPick、TargetNet预测靶点并构建化合物-靶点网络,经协同过滤算法过滤后结合KEGG富集、分子对接与网络分析识别活性化合物,并用氧糖剥夺再复氧(OGD/R)模型验证。结果显示槲皮素、黄芩苷、人参皂苷Rg1可独立及协同增加细胞活力。
要点
- 涤痰汤、血府逐瘀汤、小续命汤的化合物-靶点网络经协同过滤后保留约80%生物学功能。
- 槲皮素、黄芩苷、人参皂苷Rg1在OGD/R模型中独立及协同增加细胞活力。
- 整合药理学与化学信息学方法可识别中药复方有效协同化合物。
核心结论
- 整合药理学与化学信息学方法为识别中药复方有效协同化合物提供了新方法。
- 槲皮素、黄芩苷、人参皂苷Rg1在OGD/R模型中独立及协同增加细胞活力。
- 过滤后的化合物及其对卒中的协同效应需进一步研究。
研究设计与样本
- 从TCMSP数据库获取涤痰汤、血府逐瘀汤、小续命汤的草药与化合物。
- 用SEA、HitPick、TargetNet网络服务器进行靶点预测。
- 构建三个复方的化合物-靶点网络并用协同过滤算法过滤。
- 结合KEGG富集分析、分子对接和网络分析识别活性化合物。
- 用氧糖剥夺再复氧(OGD/R)模型验证化合物。
主要发现
- 过滤后的涤痰汤网络含39个化合物和534个靶点。
- 过滤后的血府逐瘀汤网络含40个化合物和508个靶点。
- 过滤后的小续命汤网络含55个化合物和599个靶点。
- 过滤后的化合物-靶点网络保留原始网络约80%的生物学功能。
- 构建含3个复方、14种草药、26个化合物、13个靶点、5条通路的复杂网络,并识别前5个候选化合物。
关键数值与推荐
- 过滤后的涤痰汤网络含39个化合物和534个靶点。
- 过滤后的血府逐瘀汤网络含40个化合物和508个靶点。
- 过滤后的小续命汤网络含55个化合物和599个靶点。
- 过滤后的化合物-靶点网络保留原始网络约80%的生物学功能。
- 复杂网络含3个复方、14种草药、26个化合物、13个靶点、5条通路。
临床怎么用
- 提示槲皮素、黄芩苷、人参皂苷Rg1可能为卒中后神经损伤的候选协同化合物。
- 网络药理学与化学信息学整合策略可用于中药复方协同效应研究。
- 上述化合物及协同效应需进一步研究验证后方可临床转化。
局限性
- 过滤后的化合物及其对卒中的协同效应需进一步研究。
- 研究基于数据库预测与OGD/R模型验证,未涉及临床样本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Traditional Chinese medicine (TCM) has been widely used in the treatment of human diseases. However, the synergistic effects of multiple TCM prescriptions in the treatment of stroke have not been thoroughly studied. Objective of the study: This study aimed to reveal the mechanisms underlying the synergistic effects of these TCM prescriptions in stroke treatment and identify the active compounds. Methods: Herbs and compounds in the Di-Tan Decoction (DTD), Xue-Fu Zhu-Yu Decoction (XFZYD), and Xiao-Xu-Ming Decoction (XXMD) were acquired from the TCMSP database. SEA, HitPick, and TargetNet web servers were used for target prediction. The compound-target (C-T) networks of three prescriptions were constructed and then filtered using the collaborative filtering algorithm. We combined KEGG enrichment analysis, molecular docking, and network analysis approaches to identify active compounds, followed by verification of these compounds with an oxygen-glucose deprivation and reoxygenation (OGD/R) model. Results: The filtered DTD network contained 39 compounds and 534 targets, the filtered XFZYD network contained 40 compounds and 508 targets, and the filtered XXMD network contained 55 compounds and 599 targets. The filtered C-T networks retained approximately 80% of the biological functions of the original networks. Based on the enriched pathways, molecular docking, and network analysis results, we constructed a complex network containing 3 prescriptions, 14 botanical drugs, 26 compounds, 13 targets, and 5 pathways. By calculating the synergy score, we identified the top 5 candidate compounds. The experimental results showed that quercetin, baicalin, and ginsenoside Rg1 independently and synergistically increased cell viability. Conclusion: By integrating pharmacological and chemoinformatic approaches, our study provides a new method for identifying the effective synergistic compounds of TCM prescriptions. The filtered compounds and their synergistic effects on stroke require further research.
引用
- Xu A, Wen ZH, Su SX, et al. Elucidating the Synergistic Effect of Multiple Chinese Herbal Prescriptions in the Treatment of Post-stroke Neurological Damage. Front Pharmacol. 2022. PMID: 35355727. doi:10.3389/fphar.2022.784242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。